Mesothelin has been reported as a tumour-associated marker in several types of human cancers, including ovarian carcinomas and adenocarcinomas arising from the pancreatico-biliary tract, endometrium, and lungs (Chang et al, 1992). This evidence concerns the gene MSLN and cancer.